Nanotechnology Medicine: from Cancer to COVID-19
Join us for a free talk and Q&A with UCL’s Gavin Jell, Associate Professor in Nanotechnology and Regenerative Medicine.
We are delighted to continue our UCL Medical Sciences Lecture Series throughout 2021. We believe that science can save the world, so we’ve designed these lectures to inspire year 11 and 12 students and engage them with the fascinating world of medical science.
Join us on the 22nd June at 17:00 (UK Time) for a free talk and Q&A with UCL’s Gavin Jell, Associate Professor in Nanotechnology and Regenerative Medicine, on Nanomedicine: from cancer to COVID-19.
This talk explores what nanomedicine is, the advantages nanotechnologies offer in the treatment and diagnosis of disease, and future challenges.
Nanotechnology in medicine could involve employing nanoparticles to deliver drugs, heat, light or other substances to specific types of cells (such as cancer cells). This technique reduces damage to healthy cells in the body and allows for earlier detection of disease.
Dr Jell’s research group is interested in understanding the nanoparticle (particle of matter that is between 1 and 100 nanometres in diameter) and biological interactions that occur when they are injected into the body, and how to direct these interactions so they get to the sites where we want them (and avoid accumulation at sites we don’t).
As well as his role in UCL as an associate professor, he is also a trustee for the British Society of Nanomedicine and the course Director for the BSc/MSci in Medical Innovation & Enterprise, and the MSc in Nanotechnology & Regenerative Medicine.